MDLZ vs MPLT · P/E 30, rev $38.54B vs $1.24B cap
Mondelez International Inc (MDLZ) versus MapLight Therapeutics, Inc. Common Stock (MPLT) — a side-by-side from cached financials, not a winner call.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
MPLT does not have a complete income-statement cache yet.
MDLZ currently screens at market cap $78.12B and trailing P/E 30.1. MPLT currently screens at market cap $1.24B.
Not investment advice. Open the MDLZ and MPLT stock pages for the full models.
Not investment advice.